This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)

Volume: 99, Issue: 3, Pages: 754 - 762
Published: Nov 18, 2021
Abstract
Objectives We investigated the clinical efficacy of a paclitaxel‐coated balloon (PCB) with a novel matrix coating and reduced drug concentration in comparison with a widely used PCB with iopromide excipient. Methods We prospectively enrolled patients with restenosis in drug‐eluting stents. All patients were treated with a novel low‐dose PCB with citrate‐based excipient (Agent PCB). Angiographic follow‐up was scheduled at 6–8 months. Outcomes...
Paper Details
Title
A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)
Published Date
Nov 18, 2021
Volume
99
Issue
3
Pages
754 - 762
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.